Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Our products
& pipeline
Diseases we target
GS010 for LHON
GS030 for Retinitis Pigmentosa
GS030 for Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Investors
& media
Company Overview
Press releases
Events & presentations
News and press coverage
Stock information
Governance
Documentation
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
Financial statements and reports
Regulated information
Corporate presentations
General meetings
10 May 2017
General meetings
Proxy card 2016 General Meeting
Open in new window
10 May 2017
General meetings
Nominees and renewals to the Board of Directors
Open in new window
10 May 2017
General meetings
Number of voting rights and outstanding shares
Open in new window
10 May 2017
General meetings
Report of the Board of Directors on the grant of performance shares (AGA)
Open in new window
10 May 2017
General meetings
Notice of meeting of the General Meeting on May 31, 2017
Open in new window
10 May 2017
General meetings
Supplementary report of the Board on the conversion of preferred shares on July 12, 2016
Open in new window
10 May 2017
General meetings
Supplementary report of the Board on the issuance of ordinary shares on August 10, 2016
Open in new window
28 April 2017
Financial statements and reports
2016 Registration Document
Open in new window
View previous 9 articles
1
…
8
9
10
11
12
13
Go back to the page of the page